RYTM vs. BBD-B.TO
RYTM (Rhythm Pharmaceuticals, Inc.) and BBD-B.TO (Bombardier Inc) are both stocks. RYTM operates in Biotechnology (Healthcare), while BBD-B.TO operates in Aerospace & Defense (Industrials). Over the past 5 years, RYTM returned 35.54%/yr vs 60.24%/yr for BBD-B.TO. At a 0.20 correlation, their price movements are largely independent.
Performance
RYTM vs. BBD-B.TO - Performance Comparison
Loading charts...
Different Trading Currencies
RYTM is traded in USD, while BBD-B.TO is traded in CAD. To make them comparable, the BBD-B.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, RYTM achieves a -20.86% return, which is significantly lower than BBD-B.TO's 36.22% return.
RYTM
- 1D
- 0.43%
- 1M
- -1.02%
- YTD
- -20.86%
- 6M
- -19.04%
- 1Y
- 28.99%
- 3Y*
- 68.05%
- 5Y*
- 35.54%
- 10Y*
- —
BBD-B.TO
- 1D
- -1.30%
- 1M
- 12.98%
- YTD
- 36.22%
- 6M
- 40.40%
- 1Y
- 231.43%
- 3Y*
- 76.61%
- 5Y*
- 60.24%
- 10Y*
- 19.61%
RYTM vs. BBD-B.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYTM Rhythm Pharmaceuticals, Inc. | -20.86% | 91.21% | 21.78% | 57.86% | 191.78% | -66.43% | 29.49% | -14.58% | -7.50% | -3.13% |
BBD-B.TO Bombardier Inc | 36.22% | 150.32% | 69.19% | 4.12% | 16.13% | 252.59% | -74.63% | -0.18% | -38.21% | 38.16% |
Correlation
The correlation between RYTM and BBD-B.TO is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Oct 6, 2017 | 0.20 |
The correlation between RYTM and BBD-B.TO shifts across timeframes, from 0.13 (1 year) to 0.23 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
RYTM:
$5.76B
BBD-B.TO:
CA$32.37B
RYTM:
-$3.10
BBD-B.TO:
CA$9.32
RYTM:
25.64
BBD-B.TO:
3.37
RYTM:
$217.17M
BBD-B.TO:
CA$9.60B
RYTM:
$194.16M
BBD-B.TO:
CA$1.88B
RYTM:
-$182.86M
BBD-B.TO:
CA$1.70B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RYTM vs. BBD-B.TO — Risk / Return Rank
RYTM
BBD-B.TO
RYTM vs. BBD-B.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rhythm Pharmaceuticals, Inc. (RYTM) and Bombardier Inc (BBD-B.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYTM | BBD-B.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.96 | ||
| Sortino ratioReturn per unit of downside risk | -3.55 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.62 | -0.47 |
| Calmar ratioReturn relative to maximum drawdown | 0.82 | 12.08 | -11.26 |
| Martin ratioReturn relative to average drawdown | 1.96 | 36.20 | -34.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RYTM | BBD-B.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.51 | 4.47 | -3.96 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | 1.07 | -0.60 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.32 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.18 | 0.12 | +0.06 |
Drawdowns
RYTM vs. BBD-B.TO - Drawdown Comparison
The maximum RYTM drawdown since its inception was -92.10%, roughly equal to the maximum BBD-B.TO drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for RYTM and BBD-B.TO.
Loading charts...
Drawdown Indicators
| RYTM | BBD-B.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.10% | -96.90% | +4.80% |
Max Drawdown (1Y)Largest decline over 1 year | -35.54% | -19.29% | -16.25% |
Max Drawdown (3Y)Largest decline over 3 years | -35.54% | -41.50% | +5.96% |
Max Drawdown (5Y)Largest decline over 5 years | -85.49% | -67.66% | -17.83% |
Max Drawdown (10Y)Largest decline over 10 years | — | -94.89% | — |
Current DrawdownCurrent decline from peak | -27.98% | -1.65% | -26.33% |
Average DrawdownAverage peak-to-trough decline | -32.19% | -57.60% | +25.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.81% | 6.42% | +8.39% |
Volatility
RYTM vs. BBD-B.TO - Volatility Comparison
Rhythm Pharmaceuticals, Inc. (RYTM) has a higher volatility of 16.84% compared to Bombardier Inc (BBD-B.TO) at 12.69%. This indicates that RYTM's price experiences larger fluctuations and is considered to be riskier than BBD-B.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RYTM | BBD-B.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.84% | 12.69% | +4.15% |
Volatility (6M)Calculated over the trailing 6-month period | 36.79% | 40.19% | -3.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 57.37% | 52.14% | +5.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.41% | 56.81% | +19.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.99% | 62.07% | +8.92% |
Dividends
RYTM vs. BBD-B.TO - Dividend Comparison
Neither RYTM nor BBD-B.TO has paid dividends to shareholders.
Financials
RYTM vs. BBD-B.TO - Financials Comparison
This section allows you to compare key financial metrics between Rhythm Pharmaceuticals, Inc. and Bombardier Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RYTM vs. BBD-B.TO - Profitability Comparison
RYTM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a gross profit of 52.96M and revenue of 60.11M. Therefore, the gross margin over that period was 88.1%.
BBD-B.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bombardier Inc reported a gross profit of 245.90M and revenue of 1.57B. Therefore, the gross margin over that period was 15.6%.
RYTM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported an operating income of -52.36M and revenue of 60.11M, resulting in an operating margin of -87.1%.
BBD-B.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bombardier Inc reported an operating income of 175.08M and revenue of 1.57B, resulting in an operating margin of 11.1%.
RYTM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a net income of -56.74M and revenue of 60.11M, resulting in a net margin of -94.4%.
BBD-B.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bombardier Inc reported a net income of 52.13M and revenue of 1.57B, resulting in a net margin of 3.3%.
Frequently Asked Questions
RYTM and BBD-B.TO have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for RYTM and BBD-B.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer